BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 14722913)

  • 21. Screening of TYR, OCA2, GPR143, and MC1R in patients with congenital nystagmus, macular hypoplasia, and fundus hypopigmentation indicating albinism.
    Preising MN; Forster H; Gonser M; Lorenz B
    Mol Vis; 2011 Apr; 17():939-48. PubMed ID: 21541274
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational Analysis of TYR, OCA2, and SLC45A2 Genes in Chinese Families with Oculocutaneous Albinism.
    Lin Y; Chen X; Yang Y; Che F; Zhang S; Yuan L; Wu Y
    Mol Genet Genomic Med; 2019 Jul; 7(7):e00687. PubMed ID: 31199599
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mutation analysis of a Chinese family with oculocutaneous albinism.
    Wang X; Zhu Y; Shen N; Peng J; Wang C; Liu H; Lu Y
    Oncotarget; 2016 Dec; 7(51):84981-84988. PubMed ID: 27829221
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Birth prevalence and mutation spectrum in danish patients with autosomal recessive albinism.
    Grønskov K; Ek J; Sand A; Scheller R; Bygum A; Brixen K; Brondum-Nielsen K; Rosenberg T
    Invest Ophthalmol Vis Sci; 2009 Mar; 50(3):1058-64. PubMed ID: 19060277
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oculocutaneous albinism: developing novel antibodies targeting the proteins associated with OCA2 and OCA4.
    Kondo T; Namiki T; Coelho SG; Valencia JC; Hearing VJ
    J Dermatol Sci; 2015 Jan; 77(1):21-7. PubMed ID: 25530116
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel and recurrent mutations in the tyrosinase gene and the P gene in the German albino population.
    Passmore LA; Kaesmann-Kellner B; Weber BH
    Hum Genet; 1999 Sep; 105(3):200-10. PubMed ID: 10987646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular and clinical characterization of albinism in a large cohort of Italian patients.
    Gargiulo A; Testa F; Rossi S; Di Iorio V; Fecarotta S; de Berardinis T; Iovine A; Magli A; Signorini S; Fazzi E; Galantuomo MS; Fossarello M; Montefusco S; Ciccodicola A; Neri A; Macaluso C; Simonelli F; Surace EM
    Invest Ophthalmol Vis Sci; 2011 Mar; 52(3):1281-9. PubMed ID: 20861488
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comprehensive analysis of oculocutaneous albinism among non-Hispanic caucasians shows that OCA1 is the most prevalent OCA type.
    Hutton SM; Spritz RA
    J Invest Dermatol; 2008 Oct; 128(10):2442-50. PubMed ID: 18463683
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Genetics of oculocutaneous albinism].
    Zühlke C; Stell A; Käsmann-Kellner B
    Ophthalmologe; 2007 Aug; 104(8):674-80. PubMed ID: 17646993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and Mutation Spectrum of Autosomal Recessive Non-Syndromic Oculocutaneous Albinism (nsOCA) in Pakistan: A Review.
    Ullah MI
    Genes (Basel); 2022 Jun; 13(6):. PubMed ID: 35741834
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic analyses of Chinese patients with digenic oculocutaneous albinism.
    Wei AH; Yang XM; Lian S; Li W
    Chin Med J (Engl); 2013 Jan; 126(2):226-30. PubMed ID: 23324268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NGS-based targeted sequencing identified two novel variants in Southwestern Chinese families with oculocutaneous albinism.
    Xiao Y; Zhou C; Xie H; Huang S; Wang J; Liu S
    BMC Genomics; 2022 Apr; 23(1):332. PubMed ID: 35488210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The etiology of oculocutaneous albinism (OCA) type II: the pink protein modulates the processing and transport of tyrosinase.
    Toyofuku K; Valencia JC; Kushimoto T; Costin GE; Virador VM; Vieira WD; Ferrans VJ; Hearing VJ
    Pigment Cell Res; 2002 Jun; 15(3):217-24. PubMed ID: 12028586
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oculocutaneous albinism type 1A: a case report.
    Karaman A
    Dermatol Online J; 2008 Nov; 14(11):13. PubMed ID: 19094851
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is autosomal recessive deafness associated with oculocutaneous albinism a "coincidence syndrome"?
    Lezirovitz K; Nicastro FS; Pardono E; Abreu-Silva RS; Batissoco AC; Neustein I; Spinelli M; Mingroni-Netto RC
    J Hum Genet; 2006; 51(8):716-720. PubMed ID: 16868655
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mutation spectrum of the TYR and SLC45A2 genes in patients with oculocutaneous albinism.
    Ko JM; Yang JA; Jeong SY; Kim HJ
    Mol Med Rep; 2012 Apr; 5(4):943-8. PubMed ID: 22294196
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prenatal genotyping of four common oculocutaneous albinism genes in 51 Chinese families.
    Wei AH; Zang DJ; Zhang Z; Yang XM; Li W
    J Genet Genomics; 2015 Jun; 42(6):279-86. PubMed ID: 26165494
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational Analysis on Membrane Associated Transporter Protein (MATP) and Their Structural Consequences in Oculocutaeous Albinism Type 4 (OCA4)-A Molecular Dynamics Approach.
    Kamaraj B; Purohit R
    J Cell Biochem; 2016 Nov; 117(11):2608-19. PubMed ID: 27019209
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Oculocutaneous albinism type 3 (OCA3): analysis of two novel mutations in TYRP1 gene in two Chinese patients.
    Zhang KH; Li Z; Lei J; Pang T; Xu B; Jiang WY; Li HY
    Cell Biochem Biophys; 2011 Dec; 61(3):523-9. PubMed ID: 21739261
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The oculocutaneous albinism type IV gene Matp is a new marker of pigment cell precursors during mouse embryonic development.
    Baxter LL; Pavan WJ
    Mech Dev; 2002 Aug; 116(1-2):209-12. PubMed ID: 12128226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.